Published on
April 23, 2025
- 20:22 GMT
Preclinical Data on ERX-208 and ERX-315 to Be Presented at AACR 2025
New data highlights ER stress induction via LIPA inhibition in ovarian and liver cancer; Etira’s lead candidate, ERX-315, is in clinical development. DALLAS, TX, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Etira announced three presentations at …
Distribution channels:
Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry
...
